MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with F

Fingolimod

Fingolimod 250microgram capsules

No stability information

Stability notes for Fingolimod 250microgram capsules

There are no stability notes for this medicine.

Supplier

Gilenya 0.25mg capsules (Novartis Pharmaceuticals UK Ltd)

Fingolimod 500microgram capsules

Use with caution

Stability notes for Fingolimod 500microgram capsules

Store in an airtight container and protect from moisture.

Provenance

This compatibility recommendation is derived from Gilenya 0.5mg capsules (Novartis Pharmaceuticals UK Ltd).

Suppliers (16) of Fingolimod 500microgram capsules
Fingolimod 500microgram capsules (A A H Pharmaceuticals Ltd)
Fingolimod 500microgram capsules (Accord-UK Ltd)
Fingolimod 500microgram capsules (Alliance Healthcare (Distribution) Ltd)
Fingolimod 500microgram capsules (Amarox Ltd)
Fingolimod 500microgram capsules (Dr Reddy's Laboratories (UK) Ltd)
Fingolimod 500microgram capsules (Genus Pharmaceuticals Holdings Ltd)
Fingolimod 500microgram capsules (Glenmark Pharmaceuticals Europe Ltd)
Fingolimod 500microgram capsules (MSN Laboratories Europe Ltd)
Fingolimod 500microgram capsules (Sandoz Ltd)
Fingolimod 500microgram capsules (Sun Pharma UK Ltd)
Fingolimod 500microgram capsules (Teva UK Ltd)
Fingolimod 500microgram capsules (Tillomed Laboratories Ltd)
Fingolimod 500microgram capsules (Viatris UK Healthcare Ltd)
Fingolimod 500microgram capsules (Zentiva Pharma UK Ltd)
Gilenya 0.5mg capsules (Abacus Medicine Ltd)
Gilenya 0.5mg capsules (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.